ReviewAdvances in experimental medicine and biology2026
Oral Manifestations of Autoimmune Diseases.
Review in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autoimmune diseases arise from a complex interplay between genetic predisposition and environmental factors, including chemical exposures, infections, and psychological stress. These conditions occur when the immune system mistakenly targets the body's own healthy cells, resulting in tissue and organ damage. Both humoral and cellular immune mechanisms contribute to autoimmune disorders, leading to chronic inflammation and progressive tissue injury.Autoimmune diseases have diverse and often overlapping symptoms, significantly impacting patients' quality of life. Early diagnosis is crucial for effective disease management; however, the clinical similarity among autoimmune disorders and the lack of definitive diagnostic tests in many cases pose major challenges to timely identification.Notably, in many autoimmune conditions, oral manifestations are among the earliest or, in some cases, only clinical signs, as the oral epithelium is a frequent target of autoimmune responses. These manifestations often present as erosions and ulcers, causing pain and discomfort. Identifying oral lesions at an early stage can facilitate early diagnosis and improve patient outcomes. This chapter provides a comprehensive overview of autoimmune conditions and their oral manifestations.Since immune dysregulation is central to autoimmune disease pathogenesis, local and systemic corticosteroids are commonly prescribed to control symptoms, including oral lesions. In severe or refractory cases, immunosuppressive therapies may be essential to prevent disease progression and tissue destruction.
Indexed as
Identifiers
41225103What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.